Terug
Dagbereik
€ 22,97
€ 25,56
52-Weeksbereik
€ 2,76
€ 30,60
Volume
2.057.666
50D / 200D Gem.
€ 26,18
/
€ 10,64
Vorige Slotkoers
€ 25,06
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -11,3 | 0,4 |
| P/B | 9,1 | 2,9 |
| ROE % | -86,7 | 3,8 |
| Net Margin % | -1011,8 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -370,18M
PEG of 0,47 suggests growth is underpriced
Capital efficient — spends only 2,72% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-86,69%
ROIC-94,73%
Net Margin-1011,75%
Op. Margin-1776,32%
Veiligheid
Debt / Equity
0,12
Current Ratio4,34
Interest Coverage0,00
Waardering
P/E Ratio
-11,28
P/B Ratio9,11
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 24,05M | Net Income (TTM) | -243,33M |
| ROE | -86,69% | ROA | -59,07% |
| Gross Margin | 85,46% | Operating Margin | -1776,32% |
| Net Margin | -1011,75% | Free Cash Flow (TTM) | -370,18M |
| ROIC | -94,73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 4,34 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,28 | P/B Ratio | 9,11 |
| P/S Ratio | 114,13 | PEG Ratio | 0,47 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,74B | Enterprise Value | 2,69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 24,05M | 0,0 | 0,0 | 0,0 |
| Net Income | -243,33M | -294,23M | -154,99M | -111,93M |
| EPS (Diluted) | -2,86 | -10,38 | -2,99 | -14,93 |
| Gross Profit | 20,55M | -3,15M | 0,0 | -250.000,0 |
| Operating Income | -427,20M | -300,75M | -158,17M | -113,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 411,94M | 340,99M | 89,61M | 108,17M |
| Total Liabilities | 110,64M | 80,89M | 428,87M | 303,41M |
| Shareholders' Equity | 301,30M | 260,10M | -339,26M | -195,24M |
| Total Debt | 36,91M | 30,72M | 32,58M | 1,78M |
| Cash & Equivalents | 89,67M | 169,53M | 46,00M | 25,61M |
| Current Assets | 318,23M | 306,19M | 53,36M | 102,56M |
| Current Liabilities | 73,32M | 50,91M | 20,87M | 13,35M |